Inventor · disambiguated record
Vickie Hsiao-Wei Tsui
Also filed as: TSUI VICKIE · TSUI VICKIE H · TSUI VICKIE HSIAO-WEI
36 granted patents·18 pending applications·354 citations·filing 2005–2024
97Inventor score
Files withGENENTECH INC31GILEAD SCIENCES INC12COHEN FREDERICK3CASTANEDO GEORGETTE2KOEHLER MICHAEL F T2
Top patents by PatentIndex Score
54 records- 0198US7244851B2Inhibitors of IAPGENENTECH INC·Filed 2005·Granted Jul 17, 2007·141 cites·21 claims
- 0297US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0396US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0496US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0595US7345081B2Azabicyclo-octane inhibitors of IAPGENENTECH INC·Filed 2005·Granted Mar 18, 2008·62 cites·20 claims
- 0692US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 0792US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0891US9260425B2Pyrazolo[3,4-c]pyridine compounds and methods of useDO STEVEN·Filed 2012·Granted Feb 16, 2016·29 cites·14 claims
- 0991US7846929B2Phosphoinositide 3-kinase inhibitor compounds and methods of useGENENTECH INC·Filed 2007·Granted Dec 7, 2010·20 cites·57 claims
- 1089US11096982B2Inhibitors of IAPGENENTECH INC·Filed 2019·Granted Aug 24, 2021·2 cites·30 claims
- 1187US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1286US8716236B2Inhibitors of IAPGENENTECH INC·Filed 2013·Granted May 6, 2014·5 cites·8 claims
- 1386US8450315B2Phosphoinositide 3-kinase inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2010·Granted May 28, 2013·10 cites·49 claims
- 1485US9586991B2Inhibitors of IAPGENENTECH INC·Filed 2015·Granted Mar 7, 2017·3 cites·10 claims
- 1585US8110568B2Inhibitors of IAPCOHEN FREDERICK·Filed 2010·Granted Feb 7, 2012·7 cites·4 claims
- 1683US11247989B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 15, 2022·2 cites·8 claims
- 1783US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 1883US9238675B2Inhibitors of IAPGENENTECH INC·Filed 2014·Granted Jan 19, 2016·3 cites·18 claims
- 1982US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 2081US9309240B2Pyrazolopyridine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Apr 12, 2016·6 cites·16 claims
- 2181US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2279US11963994B2Inhibitors of IAPGENENTECH INC·Filed 2021·Granted Apr 23, 2024·0 cites·10 claims
- 2379US9505767B2Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitorsGENENTECH INC·Filed 2014·Granted Nov 29, 2016·4 cites·3 claims
- 2478US9434725B25-azaindazole compounds and methods of useGENENTECH INC·Filed 2013·Granted Sep 6, 2016·4 cites·17 claims
- 2578US8247557B2IAP inhibitorsKOEHLER MICHAEL F T·Filed 2006·Granted Aug 21, 2012·4 cites·17 claims
- 2677US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 2776US10696655B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Jun 30, 2020·1 cites·20 claims
- 2876US8980837B2Inhibitors of IAPCOHEN FREDERICK·Filed 2012·Granted Mar 17, 2015·2 cites·16 claims
- 2974US9487533B2Phosphoinositide 3-kinase inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2007·Granted Nov 8, 2016·2 cites·5 claims
- 3074US8697708B2Azabenzothiazole compounds, compositions and methods of useBLENCH TOBY JONATHAN·Filed 2011·Granted Apr 15, 2014·3 cites·1 claims
- 3174US8609845B2Pyrrolidine inhibitors of IAPCOHEN FREDERICK·Filed 2009·Granted Dec 17, 2013·1 cites·13 claims
- 3270US9850239B2Pyrazolo[3,4-c]pyridine compounds and methods of useGENENTECH INC·Filed 2016·Granted Dec 26, 2017·1 cites·14 claims
- 3369US2023339981A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3468US2023374036A1Kras g12d modulating compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3566US9040706B2Pyrrolidine inhibitors of IAPGENENTECH INC·Filed 2013·Granted May 26, 2015·0 cites·4 claims
- 3666US2025059208A1Kras modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3766US2009176822A1Pyrrolidine inhibitors of iapGENENTECH INC·Filed 2008·Application pending·0 cites
- 3864US2022127265A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 3962US2024383922A1KRAS Modulating CompoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 4061US11168070B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2020·Granted Nov 9, 2021·0 cites·14 claims
- 4161US2017136084A1Inhibitors of iapGENENTECH INC·Filed 2017·Application pending·0 cites
- 4261US2007299052A1Inhibitors of IAPGENENTECH INC·Filed 2007·Application pending·0 cites
- 4360US2006167066A1Pyrrolidine inhibitors of IAPGENENTECH INC·Filed 2005·Application pending·0 cites
- 4456US2008146808A1Azabicyclo-octane inhibitors of iapGENENTECH INC·Filed 2008·Application pending·0 cites
- 4555US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4652US2014171408A1Azabenzothiazole compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4751US2012270886A1Inhibitors of iapKOEHLER MICHAEL F T·Filed 2012·Application pending·0 cites
- 4850US9505746B2Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2013·Granted Nov 29, 2016·0 cites·7 claims
- 4948US8614206B2Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useGENENTECH INC·Filed 2012·Granted Dec 24, 2013·0 cites·8 claims
- 5045US2014206702A1Imidazopyridine compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →